
Full text loading...
This study aimed to demonstrate the accuracy of a portable device for measuring nasal and bronchial fractional exhaled nitric oxide (nFeNO and FeNO) as an alternative method to replace a high-cost multiple flow device in subjects with allergic rhinitis (AR).
It was a descriptive and comparative study. The healthy subjects (control group), subjects with AR (AR group) and those with AR and asthma (AR-A group) were enrolled in this study. They underwent nasal and bronchial FeNO measurements by both fixed flow NObreath®connected to nasal mask (for nFeNO) and without mask (for FeNO) and multiple flows HypAir FeNO®.
There were 153 subjects recruited during the study period, including 63 healthy subjects and 90 subjects with AR and AR-A. There were no statistically significant differences in anthropometric characteristics between study groups. The concentrations of nasal FeNO and bronchial FeNO measured by a portable device in subjects with AR were higher than in healthy subjects: 76.0 ± 50.7 ppb vs 36.0 ± 28.1 ppb (P < 0.01), and 32.3 ± 15.4 ppb vs 9.2 ± 5.6 ppb (P < 0.001). There was a weak correlation between nasal FeNO measured by portable devices and multiple flow devices.
The portable device is useful in measuring nasal FeNO in subjects with AR. The advantages of a low-cost and accurate portable device may help it be used in primary care in the management of subjects with allergic rhinitis and asthma.
Article metrics loading...
Full text loading...
References
Data & Media loading...